EBIT at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's EBIT?
- Amphastar Pharmaceuticals (AMPH) reported EBIT of $13.63M in Q1 2026.
- How has Amphastar Pharmaceuticals's EBIT changed year-over-year?
- Amphastar Pharmaceuticals's EBIT decreased by 63.5% year-over-year, from $37.29M to $13.63M.
- What is the long-term trend for Amphastar Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's EBIT has grown at a 19.1% compound annual growth rate (CAGR), from $69.89M to $140.4M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.